Life Sciences ConferenceMarch 14, 2006 12:35 PM US Eastern Timezone
Jefferies to Host Life Sciences Conference; Industry Outlook and Trends Explored, June 27-28 in New York City
Jefferies Life Sciences Conference
NEW YORK--(BUSINESS WIRE)--March 14, 2006--Jefferies & Company, Inc., the principal operating subsidiary of Jefferies Group, Inc. (NYSE: JEF), today announced that it will host the inaugural Jefferies Life Sciences Conference on June 27-28 in New York City. The conference will attract leading public and private biotechnology, medical device, specialty pharmaceutical and contract research organizations worldwide.
Recent scientific developments aimed at lifesaving medical solutions from both emerging and mature life sciences companies have captured investors' attention. These companies are creating innovative new products and therapies to meet the challenges of unmet medical needs, increasing regulatory hurdles and escalating healthcare costs. Jefferies' two-day conference will showcase a diverse group of industry experts and life sciences companies to discuss the industry's challenges and identify opportunities for investors.
Conference participants currently include:
ACADIA Pharmaceuticals Inc. (ACAD)
Acambis plc (ACAM)
Accentia Biopharmaceuticals, Inc. (ABPI)
Advanced Magnetics, Inc. (AVM)
Affymax, Inc.
Align Technology, Inc. (ALGN)
Alkermes, Inc. (ALKS)
Allergy Therapeutics (AGYTF.PK)
Array BioPharma Inc. (ARRY)
ARYx Therapeutics, Inc.
Bavarian Nordic Group (BAVA DC)
Boston Scientific Corporation (BSX)
Cambridge Antibody Technology Group plc (CATG)
Celgene Corporation (CELG)
Cephalon, Inc. (CEPH)
Charles River Laboratories, Inc. (CRL)
CollaGenex Pharmaceuticals Inc. (CGPI)
Connetics Corporation (CNCT)
Covance Inc. (CVD)
Cubist Pharmaceuticals, Inc. (CBST)
Cyberonics, Inc. (CYBX)
Cynosure, Inc. (CYNO)
Cypress Bioscience, Inc. (CYPB)
Cytyc Corporation (CYTC)
deCODE genetics, Inc. (DCGN)
Discovery Laboratories, Inc. (DSCO)
DOV Pharmaceutical, Inc. (DOVP)
DUSA Pharmaceuticals, Inc (DUSA)
Encore Medical Corporation (ENMC)
Endo Pharmaceuticals Holdings Inc. (ENDP)
Genzyme Corporation (GENZ)
Halozyme Therapeutics, Inc. (HTI)
Hana Biosciences, Inc. (HBX)
Hologic, Inc. (HOLX)
I-Flow Corporation (IFLO)
ICON plc (ICLR)
Incyte Corporation (INCY)
InterMune, Inc. (ITMN)
Intuitive Surgical, Inc. (ISRG)
Inverness Medical Innovations, Inc. (IMA)
IRIDEX Corp. (IRIX)
Kendle International Inc. (KNDL)
Keryx Biopharmaceuticals, Inc. (KERX)
Laserscope (LSCP)
MannKind Corporation (MNKD)
Neurochem Inc. (NRMX)
Neurometrix, Inc. (NURO)
NicOx (COX.FP)
Noven Pharmaceuticals, Inc. (NOVN)
NUCRYST Pharmaceuticals Corp. (NCST)
Optimer Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc.
PAREXEL International Corporation (PRXL)
Pozen Inc. (POZN)
Protherics plc (PTIL)
SFBC International (SFCC)
Sirtris Pharmaceuticals, Inc.
SkyePharma PLC (SKYE)
Spectranetics Corp. (SPNC)
TargeGen, Inc.
ThermoGenesis Corp. (KOOL)
TorreyPines Therapeutics, Inc.
Varian Medical Systems, Inc. (VAR)
Vernalis plc (VNLS)
An audio webcast of each presentation, both live and replay, will be available at the discretion of the presenting companies, and will be accessible at www.jefferies.com.
For further information about the 2006 Jefferies Life Sciences Conference, please contact your institutional sales representative or Jodi Pulman (212.284.2581 or jpulman@Jefferies.com).